Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Hanyu Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1810-7677; OpenAlex author ID A5100778125. Sources: OpenAlex.

Their work

Papers
8 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers

Papers 8

  1. Oral and fecal microbiota as accurate non-invasive tools for detection of pancreatic cancer in the Chinese population. First author DOI 10.1016/j.canlet.2025.217456↗
  2. Integrative metagenomic and metabolomic profiling identifies gut microbial and metabolite signatures associated with lymph node metastasis in pancreatic cancer. Co-author DOI 10.3389/fmicb.2025.1706084↗
  3. Current status and prospect of gut and oral microbiome in pancreatic cancer: Clinical and translational perspectives. First author DOI 10.1016/j.canlet.2024.217274↗
  4. Difference in fecal and oral microbiota between pancreatic cancer and benign/low-grade malignant tumor patients. First author DOI 10.1186/s12866-024-03687-6↗
  5. The effect of minimally invasive or open radical antegrade modular pancreatosplenectomy on pancreatic cancer: A multicenter randomized clinical trial protocol. First author DOI 10.3389/fonc.2022.965508↗
  6. Comparison of minimal invasive versus open radical antegrade modular pancreatosplenectomy (RAMPS) for pancreatic ductal adenocarcinoma: a single center retrosp… Co-author DOI 10.1007/s00464-020-07938-1↗
  7. ROBO2 hampers malignant biological behavior and predicts a better prognosis in pancreatic adenocarcinoma. Co-author DOI 10.1080/00365521.2021.1930144↗
  8. Research Progress on Slit/Robo Pathway in Pancreatic Cancer: Emerging and Promising. Co-author DOI 10.1155/2020/2845906↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Menghua Dai · 8 shared papers, 2020–2025 · strength 1.58
  2. Pengyu Li · 3 shared papers, 2024–2025 · strength 0.81
  3. Shuai Yuan · 2 shared papers, 2024–2025 · strength 0.45
  4. Cheng Ding · 3 shared papers, 2020–2021 · strength 0.39
  5. Shunda Wang · 2 shared papers, 2020–2021 · strength 0.27
  6. Pengyu Li · 1 shared paper, 2025 · strength 0.25
  7. Wen-Jing Liu · 1 shared paper, 2025 · strength 0.25
  8. Yupei Zhao · 2 shared papers, 2021–2022 · strength 0.24
  9. Yizhi Wang · 1 shared paper, 2021 · strength 0.14
  10. Bing Peng · 1 shared paper, 2022 · strength 0.12
  11. Lei Wang · 1 shared paper, 2022 · strength 0.12
  12. Qiaofei Liu · 1 shared paper, 2022 · strength 0.12
  13. Jianwei Xu · 1 shared paper, 2022 · strength 0.12
  14. Zheng Wu · 1 shared paper, 2022 · strength 0.12
  15. Yinmo Yang · 1 shared paper, 2022 · strength 0.12
  16. Dianrong Xiu · 1 shared paper, 2022 · strength 0.12
  17. Xiaodong Tian · 1 shared paper, 2022 · strength 0.12
  18. Quan Liao · 1 shared paper, 2021 · strength 0.12
  19. Qiang Xu · 1 shared paper, 2021 · strength 0.12
  20. Xianlin Han · 1 shared paper, 2021 · strength 0.12
  21. Taiping Zhang · 1 shared paper, 2021 · strength 0.12
  22. Wenming Wu · 1 shared paper, 2021 · strength 0.12
  23. Junchao Guo · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.